8-KAccepted Oct 8, 4:30 PM ET
Childrens Place, Inc.: appoints director Elizabeth A. LaPuma
Accepted (ET)
4:30 PM
Oct 8, 2026
Filed
Oct 8, 2026
Documents
13
Size
219.8 KB
Summary
Childrens Place, Inc.: appoints director Elizabeth A. LaPuma
What happened
- The company announced that it appointed Elizabeth A. LaPuma as a member of the company's board of directors and its Audit Committee, effective Oct 2, 2026.
- Ms. LaPuma will hold office until the later of Jan 31, 2027 and the consummation of a restructuring and/or recapitalization transaction involving the company (the "Term"), unless she resigns or is removed; the company and Ms. LaPuma may mutually agree to extend her services beyond the Term until the annual meeting of stockholders in 2027.
- The filing states Ms. LaPuma is an independent director and qualifies as an "audit committee financial expert" and describes her more than 25 years of experience in financial advisory, capital markets, strategic transactions and corporate governance.
Key details
- Letter Agreement effective Sep 22, 2026: $13,500 paid on the effective date and $45,000 paid on the first business day of each successive calendar month during the Term, with a guaranteed minimum payment of $193,500 unless she resigns before the end of the Term or is terminated for cause.
- Additional cash of $5,000 for each day Ms. LaPuma spends more than four hours outside of Board meetings on non-routine activities, subject to a $50,000 cap per month unless otherwise agreed.
- Reimbursement of reasonable documented out-of-pocket business expenses in connection with her service (subject to a $50,000 cap unless otherwise agreed), customary indemnification, confidentiality arrangements and directors and officers insurance; Ms. LaPuma waives participation in any employee plan or program of the company.
Why it may matter
- This disclosure was made under Item 5.02 (Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers) and covers the appointment of a director and the compensatory terms associated with that appointment. A filing does not show why the insider traded or why the company acted.